Zoetis Inc. Cash & Equivalents 2010-2025 | ZTS
Beta
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is Zoetis Inc.'s current cash & equivalents?
Zoetis Inc. (ZTS) annual cash & equivalents for 2025 was $2.31B, a 16.36% increase from 2024. Zoetis Inc. cash & equivalents for the quarter ending December 31, 2025 was $2.31B.
What was Zoetis Inc.'s cash & equivalents in 2024?
Zoetis Inc. annual cash & equivalents for 2024 was $1.99B, a 2.65% decline from 2023.
What was Zoetis Inc.'s cash & equivalents in 2023?
Zoetis Inc. annual cash & equivalents for 2023 was $2.04B, a 43.00% decline from 2022.
What is Zoetis Inc.'s 5-year cash & equivalents CAGR?
Zoetis Inc. cash & equivalents grew at a compound annual growth rate (CAGR) of 8.50% from FY2020 to FY2025, going from $3.60B to $2.31B over 5 years.
Cash & Equivalents History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-8.5%
FY2020
$3.60B
→
FY2025
$2.31B
10111213141516171819202122232425
5 years selected
Cash & Equivalents History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.31B | +16.4% | 10-K |
| FY2024 | $1.99B | -2.6% | 10-K |
| FY2023 | $2.04B | -43.0% | 10-K |
| FY2022 | $3.58B | +2.8% | 10-K |
| FY2021 | $3.48B | -3.3% | 10-K |
| FY2020 | $3.60B | +86.3% | 10-K |
| FY2019 | $1.93B | +20.7% | 10-K |
| FY2018 | $1.60B | +2.4% | 10-K |
| FY2017 | $1.56B | +115.1% | 10-K |
| FY2016 | $727.0M | -37.0% | 10-K |
| FY2015 | $1.15B | +30.8% | 10-K |
| FY2014 | $882.0M | +44.6% | 10-K |
| FY2013 | $610.0M | +92.4% | 10-K |
| FY2012 | $317.0M | +301.3% | 10-K |
| FY2011 | $79.0M | +25.4% | 10-K |
| FY2010 | $63.0M | - | 10-K |
Company: Zoetis Inc.Ticker: ZTSSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →